Remove Bioavailability Remove Contamination Remove Pharma Companies Remove Production
article thumbnail

A winning combination: The benefits of micronization and containment in a single installation

Pharmaceutical Technology

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Additionally, over-heating of the product can affect its efficacy or shelf life and bring an increased threat of explosion.